Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Cancer medicines: a private vice for public benefit?

Richard Sullivan

Published 30 Jan 2024

https://doi.org/10.3332/ecancer.2024.ed131

PDF

The 2nd Conference and Workshop of The Cancer Genome Atlas (TCGA) in India: Towards Team Science for Multi-omics Cancer Research in South Asia

Santosh Dixit, Anguraj Sadanandam

Published 25 May 2021

https://doi.org/10.3332/ecancer.2021.ed111

PDF

COVID-19 and its ramifications for cancer patients in low-resource settings: Ghana as a case study

Nuworza Kugbey, Naomi Ohene-Oti, Verna Vanderpuye

Published 20 Apr 2020

https://doi.org/10.3332/ecancer.2020.ed99

PDF

Rediscovery in science—a second eureka moment? A case in the neovascularization in cancer

Denys N Wheatley

Published 12 Feb 2018

https://doi.org/10.3332/ecancer.2018.ed79

PDF

The case for a regional approach to publication impact

Stevan Bruijns, Camillo Lamanna

Published 29 Jan 2018

https://doi.org/10.3332/ecancer.2018.ed78

PDF

Does the oncology community have a rejection bias when it comes to repurposed drugs?

Bishal Gyawali, Pan Pantziarka, Sergio Crispino, Gauthier Bouche

Published 16 Jan 2018

https://doi.org/10.3332/ecancer.2018.ed76

PDF

Your next clinical cancer research project: preparation in a multidisciplinary environment is key

Mieke Van Hemelrijck, Cecilia Bosco

Published 14 Mar 2017

https://doi.org/10.3332/ecancer.2017.ed64

PDF | Spanish

Cancer research: quo vadis—to war?

Denys Wheatley

Published 21 Oct 2014

https://doi.org/10.3332/ecancer.2014.ed45

PDF

Meeting the current and future challenges of oncology drug development

Moira Howie, Kathy Oliver, Angela Timoney, Gordon McVie

Published 23 May 2013

https://doi.org/10.3332/ecancer.2013.ed21

PDF

A Salutary Tale - Glargine insulin and cancer risk

Peter Boyle

Published 27 Jul 2009

https://doi.org/10.3332/ecancer.2009.ed5

PDF

More from ecancer